the fluorescence of hematoporphyrin or a mixture of hematoporphyrin derivatives with affinity for neoplastic tissue. Side effects, particularly photosensitization, may occur. Small malignant lesions of the bronchus can be detected when stained with 5-aminolevulinic acid, which is inhaled. 8, 9 Laser-induced (originally, "lung imaging") fluorescence endoscopy (LIFE) 10 -12 was developed for the detection of precancerous lesions and early-stage lung cancer. The method is based on differences in the autofluorescence of noncancerous and cancerous tissues. A photosensitizer is not used. Here, we evaluated the efficacy of this method for endobronchial detection of precancerous changes and cancer, including carcinoma in situ (CIS). We explored the use of autofluorescence spectroscopy and the calculation of digital signal intensity with analysis of the signal intensity of red and green for optical biopsy of tracheobronchial lesions.
T
he annual mortality rate of lung cancer in Japan is increasing, and this disease became the most common cause of all deaths from cancer in 1998, when it first surpassed deaths from gastric cancer.
Mortality can be decreased by smokers quitting this habit, but early detection and treatment also are needed. For peripheral lung cancer, conventional radiograph images generally do not show the disease in its curable early stage; spiral CT has been used for screening for several years. The cure rate for the central type of early-stage lung cancer has been improved by endobronchial treatment such as photodynamic therapy. [1] [2] [3] Unfortunately, the lesions are difficult even for experienced bronchoscopists to identify by conventional white-light bronchoscopy. Several authors 4 -7 have reported the early detection of minute malignant lesions by methods involving the fluorescence of hematoporphyrin or a mixture of hematoporphyrin derivatives with affinity for neoplastic tissue. Side effects, particularly photosensitization, may occur. Small malignant lesions of the bronchus can be detected when stained with 5-aminolevulinic acid, which is inhaled. 8, 9 Laser-induced (originally, "lung imaging") fluorescence endoscopy (LIFE) 10 -12 was developed for the detection of precancerous lesions and early-stage lung cancer. The method is based on differences in the autofluorescence of noncancerous and cancerous tissues. A photosensitizer is not used. Here, we evaluated the efficacy of this method for endobronchial detection of precancerous changes and cancer, including carcinoma in situ (CIS). We explored the use of autofluorescence spectroscopy and the calculation of digital signal intensity with analysis of the signal intensity of red and green for optical biopsy of tracheobronchial lesions.
Materials and Methods

Subjects
A total of 65 subjects underwent bronchoscopy with LIFE. We performed a radiographic examination of heavy smokers identified as belonging to a high-risk group during mass screening for lung cancer, made available to individuals aged Ն 40 years residing in any of seven cities in Osaka Prefecture, and examined sputum specimens cytologically. Results of the sputum examination called for further study of 26 patients, who were enrolled in our trial of bronchoscopy with LIFE. Another 21 patients presented with symptoms: cough, production of sputum or bloody sputum, or some combination of these. Fifteen other patients were being monitored after the treatment of lung cancer, and 3 patients were being monitored for other disease (esophageal cancer, idiopathic thrombocytopenia, and idiopathic neutropenia). Chest radiographs showed normal findings for 59 of the 65 patients, but other findings suggested lung cancer, and the remaining 6 patients had radiographic findings suggesting early lung cancer. Forty-three patients had findings from the cytologic examination of sputum that suggested or confirmed lung cancer, and the other 22 patients had negative findings. The median age was 65 years (range, 42 to 86 years); 63 patients were men and 2 patients were women.
LIFE
The LIFE apparatus (Xillix Technologies; Richmond, BC, Canada; and Olympus Optical; Olympus; Tokyo, Japan) was developed by Hung et al 10 and Lam et al 11 at the British Columbia Cancer Research Center. When LIFE is used as well as white-light bronchoscopy, examinations take 10 to 15 min longer. As a rule, the procedure could be carried out without additional use of anesthetics. A minor tranquilizer was used if coughing was severe or if the patient complained of dyspnea. The apparatus incorporates an image-intensified charge-coupled device with a red filter (wavelengths Ն 630 nm) and green filter (wavelengths, 480 to 520 nm) under computer control. A beam of blue light with the wavelength of 442 nm produced by a helium-cadmium laser is delivered to the endobronchial wall via the illumination bundle of a fiberoptic bronchoscope, and the autofluorescence images are displayed on a red-green-blue image monitor.
Normal epithelial tissue gives off yellow-green fluorescence when excited by helium-cadmium laser light. Dysplastic tissue and CIS have less fluorescence than normal tissue. 12 
Spectrofluorometry
The spectrofluorometry system (optical multichannel analyzer IMUC-7000) was developed by Otsuka Electronics; Osaka, Japan; and Olympus cooperatively for collection of laser-induced fluorescence spectra of tissue during endoscopy. The apparatus includes an optical probe with 40 fibers for light delivery and collection. The spectrofluorometer sends data for processing and storage to the computer, and the spectrum is displayed. During the examination, the tips of the optical fibers are close to the surface of the tissue. The geometry of the laser illumination and fluorescence collection is exactly the same for both abnormal and normal sites, so the intensity of fluorescence spectra can be calibrated automatically. We examined autofluorescence measurements with this spectrofluorometer system in a preliminary study. 
Signal-Intensity Ratio of Red to Green
Pixels of LIFE images, composed of digital signals for the intensities of red and green, were analyzed. They were first saved in the tagged-image file format and then reconstructed on a computer display (Adobe Photoshop, version 5.0; Adobe Systems; Tokyo, Japan). Small areas with the typical appearance of normal bronchial tissue, metaplasia, or cancer (and verified histologically to be so) were selected, and the signal intensities of red and green were measured. The red signal intensity is affected by the total signal intensity, so we corrected for this effect by use of the red/green signal-intensity ratio.
General Methods
First, patients underwent conventional bronchoscopy done with a fiberoptic or video-assisted bronchoscope, or both. Then fluorescence bronchoscopy was done. We used a three-point scale for autofluorescence (Fig 1) . Class I images had normal fluorescence intensity and were yellow-green, class II images had somewhat less fluorescence intensity than class I images and were brown, and class III images had much less intensity than class II images and were reddish brown. Biopsies were performed on eight lesions; these were lesions of all patients seen by us during a short time when the apparatus for autofluorescence measurements was on loan to us as part of its clinical evaluation. In addition, all abnormal areas discovered by either white-light or fluorescence examination underwent biopsy for histopathologic examination, and were graded as showing mild, moderate, or severe dysplasia, or as CIS (Fig 2) .
Results
The mean cigarette index (packs of cigarettes per day times years at that consumption rate) for the 63 smokers was 55 packs (range, 5 to 140 packs), and two patients were nonsmokers. In all, 216 sites underwent biopsy. The histopathologic diagnoses of the specimens were as follows. Forty-six findings were normal. Of the 142 nonmalignant lesions, 28 were of inflammation or hyperplasia, 49 were of mild dysplasia, 44 were of moderate dysplasia, and 21 were of severe dysplasia (precancerous). Of the 23 lesions found to be lung cancer, 10 were radiographically occult, and 9 of these lesions were CIS. Five were cancers that originated in another organ.
With the histopathologic diagnosis as the standard, diagnostic accuracy by white-light bronchoscopy was 48.6% and that of LIFE was 73.1% (Table 1 ). The sensitivity of white-light bronchoscopy for detection of severe dysplasia and cancer as a single category was 61.2%, and the specificity was 85.0% (Table 2) . With the inclusion of results from LIFE, the sensitivity and specificity were 89.8% and 78.4%, respectively.
One of the nine lesions of CIS detected was seen only on LIFE images (Fig 3) . The other eight lesions were detected in the white-light images also, but for seven of the lesions, the extent of the tumor was clear on the LIFE images alone. (All of these early lung cancers could be eradicated by photodynamic therapy.) For example, Figure 4 shows CIS at the bifurcation of the right lower-lobe bronchus. As seen by white light, the tumor seemed to occupy all of the area between the right basal bronchus and right B 6 . 6 By LIFE, only part was reddish brown, and the rest looked like noncancerous tissue.
Spectrofluorometry of LIFE images of eight lesions suggested that four were invasive cancers and the remaining lesions were of CIS and of severe, moderate, and mild dysplasia. Figure 5 shows LIFE spectra from three of the images; the lesions were of severe dysplasia, CIS, and an invasive tumor. The total fluorescence intensity from tumor sites was less than that from noncancerous sites. When the fluorescence intensity of the site of invasion was expressed as a percentage of the intensity from normal sites (Fig 5, top, a) , the intensity for wavelengths from 600 to 680 nm (red fluorescence) was 190% of that for wavelengths from 500 to 550 nm (green fluorescence). For severe dysplasia and CIS, these values were 49% and 130%, respectively (Fig 5,  bottom, b) . A LIFE image of an area of moderate dysplasia is shown in Figure 6 . Pixels like the one in the Figure  6 were analyzed for red, green, and blue signal intensities (shown in the insets) and various calculations were made. In this example, the total signal intensity (Ϯ SD) in arbitrary units was 34.8 Ϯ 2.6. The mean signal intensity was 24.7 Ϯ 1.5 for red, and 46.4 Ϯ 4.1 for green. The signal intensity for blue was zero. The red/green ratio was 0.53. We plotted the red/green signal-intensity ratio against the total signal intensity for 30 areas of normal bronchial tissue, 2 areas of moderate dysplasia, and 5 areas of CIS (Fig 7) . The red/green ratios of areas of normal bronchial tissue were fairly uniform whatever the total signal intensity. The total signal intensities of areas of moderate dysplasia and CIS were low, without exception. The red/green ratios of moderate dysplasia were slightly higher than those of normal tissue. These ratios for CIS were higher than those of the normal tissue.
Discussion
The combination of conventional bronchoscopy and LIFE can improve detection of endobronchial lesions. 13, 14 We found the sensitivity in detection of severe dysplasia and cancer, including CIS, by this combination to be 29 percentage points higher (improvement by slightly less than 50%) than by conventional bronchoscopy alone. The specificity with this combination was lower by about 7 percentage points. We concluded that all sites considered suspicious by either method should be examined.
The extent of the tumor in patients with CIS was not apparent by the conventional method, but in general could be identified by LIFE.
Autofluorescence of tissues can change if the epithelial layer thickens, or if the concentration in the tissue of certain substances, including flavins, collagen, and nicotinamide adenine dinucleotide (NADH), changes. For example, red autofluorescence (at wavelength of 600 to 680 nm) may be greater in tumor tissues because the amount of porphyrin increases as a result of tumor hypervascularity. 15 Reasons for the differences in autofluorescence of tumor tissue compared with normal tissue are not understood in detail.
Vo-Dinh et al 16 suggest division of the amplitude of fluorescence intensity at each wavelength by the integrated area under the spectrum from 430 to 720 nm to eliminate error arising during in vivo measure- ments and also to amplify differences in the lowintensity spectra of altered tissues. However, we found during comparison of fluorescence spectra of normal bronchial tissue and tissues with severe dysplasia or cancer that even without such correction, differences in the fluorescence intensity were obvious. The LIFE images showed both severe dysplasia and CIS as class III by our classification.
Cancer cells contain a higher concentration of protoporphyrin derivatives than normal cells because of impaired heme metabolism. 15 For that reason, the emission of red fluorescence on excitation of cancerous tissue by blue light increases more than the emission of green fluorescence. Our results suggested that the detection of cancer and metaplasia by LIFE images may be improved by the plotting of red/green ratios.
LIFE is useful for the early detection of minute malignant lesions that could be overlooked by conventional bronchoscopy. It might be used in the screening of high-risk subjects with suspected occult lung cancer. Results obtained by analysis of spectrofluorescence and the red/green signal intensity ratio give a more objective basis for the diagnosis of precancerous and cancerous lesions than evaluation by eye.
For the endobronchial treatment of early-stage lung cancers of the central type by photodynamic therapy, LIFE can be done to identify the extent of any dysplasia or cancer found. Endoscopic ultrasonography done in addition to LIFE can show deep invasion of the bronchial wall, 17 so that correct decisions about treatment can be made.
ACKNOWLEDGMENT: We thank Mr. Mamoru Kaneko, Dr. Hiroyuki Yano, and Dr. Ken Kodama for technical assistance with the spectrofluorescence analyzer. We thank Olympus Co., Ltd., for technical support in the development of the LIFE lung system. 
